The induction of tolerance is a long-standing goal in transplantation. Intact MHC molecules, or fragments of them, are being used to render T cells unresponsive both in vitro and in vivo. Elucidation of the mechanisms underlying the effects of these treatments should aid the design of novel therapies for transplantation.
|Original language||English (US)|
|Number of pages||5|
|Journal||Current Opinion in Immunology|
|State||Published - Oct 1995|
ASJC Scopus subject areas
- Immunology and Allergy